Smaregi, Inc. (TYO:4431)

G1 Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2018
Period Ending	Aug 13, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2018
Market Capitalization	67,895	60,580	43,723	54,080	20,557	-
Market Cap Growth	33.66%	38.55%	-19.15%	163.08%	-	-
Enterprise Value	62,083	54,891	38,657	50,307	16,692	-
Last Close Price	3525.00	3145.00	2264.29	2810.70	1050.03	-
PE Ratio	41.46	36.96	36.05	60.93	36.91	-
Forward PE	-	41.29	41.29	41.29	-	-
PS Ratio	6.14	5.47	5.21	9.14	4.79	-
PB Ratio	8.86	7.90	7.33	11.55	4.77	-
P/TBV Ratio	10.77	9.61	7.64	12.44	5.03	-
P/FCF Ratio	34.82	31.07	30.49	58.97	96.06	-
P/OCF Ratio	27.54	24.58	25.55	54.82	92.60	-
EV/Sales Ratio	5.61	4.96	4.61	8.51	3.89	-
EV/EBITDA Ratio	22.64	20.02	19.79	48.01	22.93	-
EV/EBIT Ratio	26.13	23.10	22.28	56.28	26.66	-
EV/FCF Ratio	31.84	28.15	26.96	54.86	78.00	-
Debt / Equity Ratio	0.01	0.01	-	-	-	0.05
Debt / EBITDA Ratio	0.04	0.04	-	-	-	-
Debt / FCF Ratio	0.05	0.05	-	-	-	-
Asset Turnover	1.19	1.19	1.19	1.03	-	1.97
Inventory Turnover	6.40	6.40	5.55	5.67	-	17.47
Quick Ratio	2.41	2.41	3.14	3.25	4.33	1.82
Current Ratio	2.79	2.79	3.67	3.72	4.95	2.02
Return on Equity (ROE)	24.04%	24.04%	22.78%	19.75%	-	55.24%
Return on Assets (ROA)	15.95%	15.95%	15.37%	9.71%	-	26.86%
Return on Capital (ROIC)	21.62%	21.62%	20.37%	12.43%	-	39.58%
Return on Capital Employed (ROCE)	30.20%	30.20%	28.60%	18.70%	14.20%	58.50%
Earnings Yield	2.41%	2.71%	2.77%	1.64%	2.71%	-
FCF Yield	2.87%	3.22%	3.28%	1.70%	1.04%	-
Dividend Yield	0.56%	0.48%	-	-	-	-
Buyback Yield / Dilution	-0.17%	-0.13%	0.05%	1.62%	-27.35%	-1.37%
Total Shareholder Return	0.39%	0.35%	0.05%	1.62%	-27.35%	-1.37%

Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.